Strongbridge Bio Ord (SBBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 30,731 | 21,712 | 18,027 | 7,046 | 0 |
| Cost of Goods | 2,212 | 3,822 | 3,986 | 1,483 | N/A |
| Gross Profit | 28,519 | 17,890 | 14,041 | 5,563 | N/A |
| Operating Expenses | 71,896 | 85,805 | 96,950 | 79,788 | 50,726 |
| Operating Income | -43,165 | -67,093 | -81,923 | -73,742 | -50,726 |
| Interest Expense | 1,336 | 0 | 12,515 | 4,313 | 20 |
| Other Income | -589 | 19,410 | 126,825 | -33,657 | -611 |
| Pre-tax Income | -45,090 | -47,683 | 32,387 | -111,712 | -51,357 |
| Income Tax | -15 | 1,768 | 536 | 1,771 | -2,638 |
| Net Income Continuous | -45,075 | -49,451 | 31,851 | -113,483 | -48,719 |
| Minority Interests | N/A | N/A | N/A | N/A | -122 |
| Net Income | $-45,075 | $-49,451 | $31,851 | $-113,483 | $-48,597 |
| EPS Basic Total Ops | -0.78 | -0.91 | 0.69 | -3.11 | -2.26 |
| EPS Basic Continuous Ops | -0.78 | -0.91 | 0.69 | -3.11 | -2.26 |
| EPS Diluted Total Ops | -0.78 | -1.10 | 0.31 | -3.11 | -2.27 |
| EPS Diluted Continuous Ops | -0.78 | -0.89 | 0.64 | -3.11 | -2.25 |
| EPS Diluted Before Non-Recurring Items | -0.78 | -1.10 | 0.31 | -1.45 | -1.54 |
| EBITDA(a) | $-38,058 | $-61,994 | $-74,690 | $-68,710 | $-50,716 |